JonesTrading Initiates Coverage On Monopar Therapeutics with Buy Rating

JonesTrading analyst Soumit Roy initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Buy rating.

Benzinga · 02/03/2020 14:27

JonesTrading analyst Soumit Roy initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Buy rating.